Table 1.
Descriptive data of the study subjects (n = 24).
| |
N |
Mean |
|
SD |
| Age (years) |
24 |
40 |
|
9 |
| Anthropometry and body composition | ||||
| Body mass index (kg/m2) | 24 | 31.6 | ± | 4.5 |
| Waist circumference (cm) | 24 | 107.1 | ± | 11.1 |
| Lean body mass (kg) | 24 | 58.1 | ± | 6.6 |
| Lean mass index (kg/m2) | 24 | 19.0 | ± | 2.3 |
| Fat mass (kg) | 24 | 33.7 | ± | 8.6 |
| Fat mass index (kg/m2) | 24 | 11.0 | ± | 2.7 |
| Body fat percentage (%) | 24 | 35.3 | ± | 4.9 |
| Visceral adipose tissue mass (g) |
24 |
818 |
± |
320 |
|
Fasting cardiometabolic profile | ||||
| Glucose (mg/dL) | 23 | 94 | ± | 8 |
| Insulin (μIU/mL) | 23 | 11 | ± | 6 |
| HOMA-index | 22 | 2.6 | ± | 1.4 |
| GTP (IU/L) | 23 | 33 | ± | 15 |
| GGT (IU/L) | 23 | 42 | ± | 29 |
| ALP (IU/L) | 23 | 72 | ± | 21 |
| Total cholesterol (mg/dL) | 23 | 201 | ± | 28 |
| HDL-C (mg/dL) | 22 | 48 | ± | 9 |
| LDL-C (mg/dL) | 22 | 130 | ± | 21 |
| Triglycerides (mg/dL) | 23 | 129 | ± | 51 |
| Systolic blood pressure (mmHg) | 24 | 126 | ± | 14 |
| Diastolic blood pressure (mmHg) |
24 |
86 |
± |
11 |
|
MFO, FATmax and cardiorespiratory fitness |
|
|
||
| MFO (g/min) | 24 | 0.24 | ± | 0.09 |
| MFO/LM (mg/kg/min) | 24 | 4.05 | ± | 1.43 |
| FATmax (%VO2peak) | 24 | 33 | ± | 7 |
| VO2peak (mL/min) | 24 | 2845 | ± | 473 |
| VO2peak/lean mass (mL/kg/min) | 24 | 30 | ± | 6 |
Data are presented as mean and standard deviation (SD). ALP, alanine phosphatase, GGT: gamma-glutamyl transferase, GPT: glutamate-pyruvate transaminase, HDL-C: High-density lipoprotein-cholesterol, HOMA: homeostatic model assessment, LDL-C: Low-density lipoprotein-cholesterol, LM: lean mass, MFO: maximal fat oxidation, VO2: volume of oxygen.